iCAD announces availability of its SecondLook Digital with Agfa HealthCare's Computed Radiography Systems in Europe.NASHUA, N.H. -- In release dated Dec. 29, 2008, headline should read: iCAD announces availability of its SecondLook Digital with Agfa HealthCare's Computed Radiography radiography: see X ray. Systems in Europe (sted iCAD announces availability of its SecondLook Digital with Agfa HealthCare's CR Digitizers in Europe). The corrected release reads: ICAD ANNOUNCES AVAILABILITY OF ITS SECONDLOOK DIGITAL WITH AGFA HEALTHCARE'S COMPUTED RADIOGRAPHY SYSTEMS IN EUROPE iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis and workflow solutions for the early identification of cancer, today announced that its SecondLook([R]) Digital CAD technology customized for use with Agfa HealthCare's Computed Radiography Systems is now available throughout Europe. "iCAD for CR Mammography mammography, diagnostic procedure that uses low-dose X rays to detect abnormalities in the breasts. The early diagnosis of breast cancer made possible by the routine use of mammography for screening women increases a woman's treatment alternatives and improves her has simplified life and makes us more efficient", said Dr. Fenzl, M.D., Head of Radiology for Diagnostic and Interventional Radiology interventional radiology Imaging A subspecialty of radiology that provides Diagnostic information–eg, CT-guided 'skinny' needle biopsies and dye injection for analysis of various lumina and tracts–eg, arteriography, cholangiography, antegrade and Nuclear Medicine at Bundes-Knappschaftkrankenhaus Puttlingen, Saarland in Germany. He continued, "In fact iCAD is a great aid where it comes to challenging mammography cases as it helps detecting difficult to spot cancers. At the beginning I was rather skeptical and kept a certain distance. However, after having used the iCAD system for a couple of weeks it has really added value. It increases confidence and it would be hard to go back to the days where iCAD was not used. Our radiologists are using it on a daily basis and it smoothly integrates in our digital workflow. " iCAD has received CE mark approval to market and sell its customized solution with Agfa HealthCare's Computed Radiography Systems and units have been placed at Bundes-Knappschaftkrankenhaus Puttlingen in Germany. "The availability of our CAD technology with Agfa Healthcare's solutions in Europe marks another milestone in our business strategy to increase the use of iCAD systems outside of the U.S.," said Ken Ferry, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of iCAD. "Our new partnership underscores Agfa's leadership in diagnostic image management solutions and our shared commitment to improving early detection of breast cancer in Europe." About Agfa HealthCare Agfa HealthCare, a member of the Agfa-Gevaert Group, is a leading provider of IT-enabled clinical workflow and diagnostic image management solutions, and state-of-the-art systems for capturing and processing images in hospitals and healthcare facilities. Agfa HealthCare has over a century of healthcare experience related to diagnostic imaging and has been a pioneer on the healthcare IT market since the early 1990's. The HealthCare division has sales offices and agents in over 100 markets worldwide. Sales for Agfa HealthCare in 2007 were 1,392 million Euro, accounting for 43% of total group sales Group sales Block sale (of large amounts) of securities to institutional investors. group sales The distribution of a new security issue to institutional clients. . About iCAD, Inc. iCAD, Inc. is an industry-leading provider of advanced image analysis and workflow solutions that enable healthcare professionals to better serve patients by identifying pathologies and pinpointing cancer earlier. iCAD offers a comprehensive range of high-performance, upgradeable Computer-Aided Detection (CAD) systems and workflow solutions for mammography (film-based, digital radiography digital radiography Imaging A format for producing x-rays in which film used to produce conventional x-ray images is replaced with more sensitive sensitive electronics; DXRs produce images with1⁄2 (DR) and computed radiography (CR), Magnetic Resonance Imaging magnetic resonance imaging (MRI), noninvasive diagnostic technique that uses nuclear magnetic resonance to produce cross-sectional images of organs and other internal body structures. (MRI 1. (application) MRI - Magnetic Resonance Imaging. 2. MRI - Measurement Requirements and Interface. ), and Computed Tomography Computed tomography (CT scan) X rays are aimed at slices of the body (by rotating equipment) and results are assembled with a computer to give a three-dimensional picture of a structure. (CT). Currently available in more than 2,200 healthcare centers worldwide, iCAD's solutions aid in the early detection of the most prevalent cancers including breast, colon, prostate and in the future, lung cancer lung cancer, cancer that originates in the tissues of the lungs. Lung cancer is the leading cause of cancer death in the United States in both men and women. Like other cancers, lung cancer occurs after repeated insults to the genetic material of the cell. . For more information, call (877) iCADnow or visit www.icadmed.com. "Safe Harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. " Statement under the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995: Certain statements contained in this News Release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve a number of known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, but are not limited to, the risks of uncertainty of patent protection, the impact of supply and manufacturing constraints or difficulties, product market acceptance, possible technological obsolescence ob·so·les·cent adj. 1. Being in the process of passing out of use or usefulness; becoming obsolete. 2. Biology Gradually disappearing; imperfectly or only slightly developed. , increased competition, customer concentration and other risks detailed in the Company's filings with the Securities and Exchange Commission. The words "believe", "demonstrate", "intend", "expect", "estimate", "anticipate", "likely", and similar expressions identify forward-looking statements. Readers are cautioned not to place undue reliance on those forward-looking statements, which speak only as of the date the statement was made. The Company is under no obligation to provide any updates to any information contained in this release. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion